Global Pediatric Drugs Market Trends, Size, Competitive Analysis and Forecast 2020-2026

The pediatric drugs market is projected to grow at a considerable CAGR of around 5% during the, forecast period (2020-2026). The growing prevalence of several disorders such as asthma, anorexia, birth defects, cancer in children, growth deficiencies, juvenile diabetes, and attention deficit hyperactivity among others is a major factor creating the demand for pediatric drugs. The presence of several acts such as Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) is further propelling the major players to increase the investments on R&D activities for the development of the pediatric drugs. Furthermore, the growing pediatric population across the globe is predicted to accelerate the demand for pediatric drugs which in turn, is anticipated to drive the market growth. According to the US-based non-profit organization Child Trends, in 2017, there were 73.7 million children younger than 18 in the US, accounting for 22.6% of the total population.

To Request a Sample of our Report on Global Pediatric Drugs Market: https://www.omrglobal.com/request-sample/pediatric-drugs-market
In addition, growing R&D activities in pediatric drugs, improvements in the immunization program and the proliferation of pediatric drugs in the emerging countries are among the major factors that are promoting the growth of the pediatric drugs market during the forecast period. However, the lack of accessibility of pediatric drugs in emerging countries due to lack of awareness and healthcare infrastructure are the major factors that are anticipated to restrict the growth of the global pediatric drugs market. In addition, side effects associated with the dosage of pediatric drugs such as anxiety, headache, and fatigue are the other factors to restrain its market growth.

(Get 15% Discount on Buying this Report)
A full Report of Global Pediatric Drugs Market is Available at: https://www.omrglobal.com/industry-reports/pediatric-drugs-market

Global Pediatric Drugs Market Segmentation

By Drug Type

• Allergy and Respiratory Drugs
• Cancer Therapies
• Cardiovascular Drugs
• Gastrointestinal Drugs
• Others

By Route of Administration

• Oral
• Topical
• Parenteral
• Other (Buccal)

By Application

• Pediatric Clinical Pharmacology
• Pediatric Pharmacotherapy
• Pediatric Pharmacy

Regional Analysis

North America

• United States
• Canada

Europe
• UK
• Germany
• Spain
• France
• Italy
• Rest of Europe

Asia-Pacific
• India
• China
• Japan
• Rest oF APAC
Rest of The World

Company Profiles

• Abbott Laboratories Inc.
• Allergan PLC
• AstraZeneca PLC
• AYTU BioScience, Inc.
• Bayer AG
• BioMarin Pharmaceutical, Inc.
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co.
• Eisai Inc
• Eli Lilly Co.
• F. Hoffman La Roche, Ltd.
• Genentech, Inc.
• GlaxoSmithKline PLC
• Johnson & Johnson, Inc.
• Mallinckrodt PLC
• Merck KGaA
• Novartis International AG
• Novo Nordisk A/S
• Pfizer, Inc.
• Teva Pharmaceutical Industries, Ltd.

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pediatric-drugs-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.